Foundation Medicine Establishes ImmunoOncology Companion Diagnostics Collaboration with Merck

PanCancer MSI Companion Diagnostic for KEYTRUDAÂ pembrolizumab Planned for Inclusion on FoundationOne CDx Foundation Medicine Inc. NASDAQFMI today announced a collab…
Read the full story: Bioportfolio Biomarker News